{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:43:30Z","timestamp":1788871410465,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["90913023"],"award-info":[{"award-number":["90913023"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31370900"],"award-info":[{"award-number":["31370900"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20131282"],"award-info":[{"award-number":["BK20131282"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Province Clinical Science and Technology Project (Clinical Research Center","award":["BL2012008"],"award-info":[{"award-number":["BL2012008"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.taap.2014.12.015","type":"journal-article","created":{"date-parts":[[2015,1,6]],"date-time":"2015-01-06T12:44:28Z","timestamp":1420548268000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Preferential cytotoxicity of bortezomib toward highly malignant human liposarcoma cells via suppression of MDR1 expression and function"],"prefix":"10.1016","volume":"283","author":[{"given":"Yamei","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqian","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2014.12.015_bb0005","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1535-6108(04)00120-5","article-title":"The development of proteasome inhibitors as anticancer drugs","volume":"5","author":"Adams","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.taap.2014.12.015_bb0010","doi-asserted-by":"crossref","first-page":"C620","DOI":"10.1152\/ajpcell.00457.2002","article-title":"Effect of ouabain on CFTR gene expression in human Calu-3 cells","volume":"284","author":"Baudouin-Legros","year":"2003","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.taap.2014.12.015_bb0015","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/sj.onc.1206056","article-title":"NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells","volume":"22","author":"Bentires-Alj","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.taap.2014.12.015_bb0020","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1158\/0008-5472.CAN-07-6483","article-title":"The novel polyamine analogue CGC-11093 enhances the antimyeloma activity of bortezomib","volume":"68","author":"Carew","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2014.12.015_bb0025","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1182\/blood-2004-02-0547","article-title":"Targeting mitochondria to overcome conventional and bortezomib\/proteasome inhibitor PS-341 resistance in multiple myeloma (MM) cells","volume":"104","author":"Chauhan","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.taap.2014.12.015_bb0030","doi-asserted-by":"crossref","first-page":"483154","DOI":"10.1155\/2011\/483154","article-title":"Liposarcoma: molecular genetics and therapeutics","volume":"2011","author":"Conyers","year":"2011","journal-title":"Sarcoma"},{"key":"10.1016\/j.taap.2014.12.015_bb0035","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fphar.2013.00068","article-title":"Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy","volume":"4","author":"Crawford","year":"2013","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2014.12.015_bb0040","doi-asserted-by":"crossref","first-page":"9323","DOI":"10.1158\/0008-5472.CAN-08-2873","article-title":"Preferential cytotoxicity of bortezomib toward hypoxic tumor cells via overactivation of endoplasmic reticulum stress pathways","volume":"68","author":"Fels","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2014.12.015_bb0045","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/ijc.21063","article-title":"Proteasome inhibitors can alter the signaling pathways and attenuate the P-glycoprotein-mediated multidrug resistance","volume":"117","author":"Fujita","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.taap.2014.12.015_bb0050","first-page":"785","article-title":"Novel therapeutic avenues in myeloma: changing the treatment paradigm","volume":"21","author":"Ghobrial","year":"2007","journal-title":"Oncology"},{"key":"10.1016\/j.taap.2014.12.015_bb0055","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1182\/blood-2009-01-199604","article-title":"Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cells","volume":"114","author":"Hideshima","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.taap.2014.12.015_bb0060","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/path.4259","article-title":"New drug targets in metastatic melanoma","volume":"232","author":"Homet","year":"2014","journal-title":"J. Pathol."},{"key":"10.1016\/j.taap.2014.12.015_bb0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1586\/era.09.184","article-title":"Do stem-like cells play a role in drug resistance of sarcomas?","volume":"10","author":"Honoki","year":"2010","journal-title":"Expert. Rev. Anticancer. Ther."},{"key":"10.1016\/j.taap.2014.12.015_bb0070","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3322\/canjclin.56.2.106","article-title":"Cancer statistics, 2006","volume":"56","author":"Jemal","year":"2006","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.taap.2014.12.015_bb0075","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1016\/j.ejca.2005.07.023","article-title":"Differential sensitivity of liposarcoma subtypes to chemotherapy","volume":"41","author":"Jones","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.taap.2014.12.015_bb0080","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1158\/1535-7163.MCT-07-2375","article-title":"Ritonavir induces endoplasmic reticulum stress and sensitizes sarcoma cells toward bortezomib-induced apoptosis","volume":"7","author":"Kraus","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.taap.2014.12.015_bb0085","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.onc.1205117","article-title":"Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-kappaB signaling","volume":"21","author":"Kuo","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.taap.2014.12.015_bb0090","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10495-006-4689-y","article-title":"JNK and AP-1 mediate apoptosis induced by bortezomib in HepG2 cells via FasL\/caspase-8 and mitochondria-dependent pathways","volume":"11","author":"Lauricella","year":"2006","journal-title":"Apoptosis"},{"key":"10.1016\/j.taap.2014.12.015_bb0095","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00000658-199809000-00008","article-title":"Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution","volume":"228","author":"Lewis","year":"1998","journal-title":"Ann. Surg."},{"key":"10.1016\/j.taap.2014.12.015_bb0100","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrc2171","article-title":"Calcium and cancer: targeting Ca2+ transport","volume":"7","author":"Monteith","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.taap.2014.12.015_bb0105","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3892\/ijo.2013.1870","article-title":"Macrolide antibiotics block autophagy flux and sensitize to bortezomib via endoplasmic reticulum stress-mediated CHOP induction in myeloma cells","volume":"42","author":"Moriya","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.taap.2014.12.015_bb0110","first-page":"803","article-title":"The mechanism of cross-resistance to proteasome inhibitor bortezomib and overcoming resistance in Ewing's family tumor cells","volume":"31","author":"Nakamura","year":"2007","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.taap.2014.12.015_bb0115","doi-asserted-by":"crossref","first-page":"11658","DOI":"10.1158\/0008-5472.CAN-05-2370","article-title":"Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis","volume":"65","author":"Nawrocki","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2014.12.015_bb0120","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s00280-013-2136-7","article-title":"The interaction of bortezomib with multidrug transporters: implications for therapeutic applications in advanced multiple myeloma and other neoplasias","volume":"71","author":"O'Connor","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.taap.2014.12.015_bb0125","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1146\/annurev.med.57.042905.122625","article-title":"Bortezomib: proteasome inhibition as an effective anticancer therapy","volume":"57","author":"Richardson","year":"2006","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.taap.2014.12.015_bb0130","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/j.1476-5381.2009.00117.x","article-title":"Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glycoprotein overexpression","volume":"156","author":"Riganti","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2014.12.015_bb0135","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2174\/138920106779116865","article-title":"Bortezomib as an antitumor agent","volume":"7","author":"Roccaro","year":"2006","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.taap.2014.12.015_bb0140","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bbrc.2007.07.049","article-title":"Knockdown of PgP resensitizes leukemic cells to proteasome inhibitors","volume":"361","author":"Rumpold","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.taap.2014.12.015_bb0145","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00109-006-0150-5","article-title":"The unfolded protein response and cancer: a brighter future unfolding?","volume":"85","author":"Scriven","year":"2007","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.taap.2014.12.015_bb0150","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/01.sla.0000086542.11899.38","article-title":"Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma","volume":"238","author":"Singer","year":"2003","journal-title":"Ann. Surg."},{"key":"10.1016\/j.taap.2014.12.015_bb0155","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.4065\/82.11.1409","article-title":"Sarcoma","volume":"82","author":"Skubitz","year":"2007","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.taap.2014.12.015_bb0160","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.lfs.2014.01.067","article-title":"High expression of sarcoplasmic\/endoplasmic reticulum Ca(2+)-ATPase 2b blocks cell differentiation in human liposarcoma cells","volume":"99","author":"Wang","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2014.12.015_bb0165","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1158\/1535-7163.MCT-11-0487","article-title":"Integrin alpha6(high) cell population functions as an initiator in tumorigenesis and relapse of human liposarcoma","volume":"10","author":"Wang","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.taap.2014.12.015_bb0170","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1158\/1535-7163.MCT-10-0812","article-title":"Targeting sarcoplasmic\/endoplasmic reticulum Ca(2)+\u2212ATPase 2 by curcumin induces ER stress-associated apoptosis for treating human liposarcoma","volume":"10","author":"Wang","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.taap.2014.12.015_bb0175","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1212\/01.wnl.0000192306.98198.ec","article-title":"The unfolded protein response: a stress signaling pathway critical for health and disease","volume":"66","author":"Zhang","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.taap.2014.12.015_bb0180","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4161\/cbt.7.4.5483","article-title":"Proteasome inhibitor MG132 reverses multidrug resistance of gastric cancer through enhancing apoptosis and inhibiting P-gp","volume":"7","author":"Zhang","year":"2008","journal-title":"Cancer Biol. Ther."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X14004530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X14004530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T13:50:05Z","timestamp":1598622605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X14004530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0041008X14004530"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2014.12.015","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preferential cytotoxicity of bortezomib toward highly malignant human liposarcoma cells via suppression of MDR1 expression and function","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2014.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}